-
Reliance Industr
1,411.85 1,608.95(%) -
Mazagon Dock
3,149.70 3,149.70(%) -
Bajaj Finance
8,560.00 6,376.55(%) -
Garden Reach Sh.
1,855.00 890.05(%) -
Cochin Shipyard
1,575.50 1,169.00(%) -
Tata Motors
641.10 542.55(%) -
Hind.Aeronautics
4,466.00 3,045.95(%) -
Paras Defence
1,469.00 1,592.75(%) -
Torrent Pharma.
3,300.00 2,513.05(%) -
Sonata Software
446.50 762.00(%) -
Data Pattern
2,450.00 1,350.50(%) -
IndusInd Bank
843.10 1,550.00(%) -
Samvardh. Mothe.
131.75 107.30(%) -
Bharat Electron
312.50 221.00(%) -
Trent
5,130.00 4,197.50(%) -
Varun Beverages
507.45 419.40(%) -
ICICI Bank
1,415.10 1,051.50(%) -
Vedanta
423.20 527.00(%) -
Hitachi Energy
14,879.00 16,534.50(%) -
Tech Mahindra
1,510.60 1,807.40(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Divis Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs
- Indian Private
- BSE Code : 21188.0
- ISIN : INE361B01024
-
Today’s Low
6,015.50 -
Today’s High
6,136.00

-
Open
6,115.50 -
Perv Close
6,108.00 -
52W Low
3,724.00 -
52W High
6,308.50
Key Indicators
-
P/E(TTM)
77.94
-
Mar.Cap (₹Cr.)
161,590.72
-
Div & Yield %
0.49
-
Book Value(₹)
513.62
-
Debt-Equity Ratio
-0.34
-
AGM Date
30-Apr-2025
-
EPS
78.09
-
P/E Ratio
77.94
Financials Ratios
-
Debt-Equity Ratio
0.00
-
Mar.Cap (₹Cr.)
161,590.72
-
RONW (%)
12.15
-
ROCE (%)
16.41
Score Board
-
Equity (₹ in Cr.)
53.09
-
BV (₹)
513.60
-
Sales( ₹ in Cr.)
7,665.00
-
NP (in Cr.)
1,575.26
-
NP Var(%)
-13.0
-
Div%
1500.0
-
CPS (₹)
73.50
-
EPS (₹)
59.30
-
Traded Value (₹ in Lakhs)
162,251.74
-
52 Week High
6,308.50
-
52 Week Low
3,724.00
-
Price BSE
6112.0
-
Price NSE
6,108.00
-
Market Capital( in Cr.)
162,251.74
-
P/C Ratio
83.20
-
P/E Ratio
103.00
-
Price Vs.BV
59.30
-
24-Apr-2025( 01:45)
Hot Pursuit - Divis... - In its latest note, the broker...
-
21-Apr-2025( 10:18)
Hot Pursuit - Divis... - In a regulatory filing on 18 A...
-
18-Apr-2025( 10:02)
Corporate News - Divis... - Divis Laboratories has signed...
-
31-Mar-2025( 10:14)
Corporate News - Divi'... - Divi's Laboratories announced...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 7,665.00 | 7,625.00 | 8,879.82 | 6,798.61 | 5,310.57 | 4,879.66 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 7,665.00 | 7,625.00 | 8,879.82 | 6,798.61 | 5,310.57 | 4,879.66 |
Other Income | 337.00 | 349.00 | 111.26 | 62.53 | 189.86 | 156.58 |
Stock Adjustments | 127.00 | -50.00 | 449.99 | 100.00 | 94.10 | 244.22 |
Total Income | 8,129.00 | 7,924.00 | 9,441.07 | 6,961.14 | 5,594.53 | 5,280.46 |
EXPENDITURE : | ||||||
Raw Materials | 3,270.00 | 3,035.00 | 3,499.18 | 2,416.47 | 2,223.95 | 2,120.64 |
Power and Fuel Cost | 477.00 | 496.00 | 390.05 | 319.15 | 280.73 | 248.78 |
Employee Cost | 1,067.00 | 953.00 | 926.55 | 808.68 | 608.36 | 530.72 |
Other Manufacturing Expenses | 299.00 | 285.00 | 255.38 | 202.29 | 184.36 | 138.96 |
Selling and Administration Expenses | 367.00 | 402.00 | 340.16 | 292.53 | 222.86 | 171.84 |
Miscellaneous Expenses | 137.00 | 55.00 | 40.95 | 37.69 | 68.00 | 62.87 |
Employee Benefit Expenses | 1,067.00 | 953.00 | 926.55 | 808.68 | 608.36 | 530.72 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 5,617.00 | 5,226.00 | 5,452.27 | 4,076.81 | 3,588.26 | 3,273.81 |
Operating Profit | 2,512.00 | 2,698.00 | 3,988.80 | 2,884.33 | 2,006.27 | 2,006.65 |
Interest | 4.00 | 2.00 | 1.73 | 1.81 | 7.03 | 4.61 |
Gross Profit | 2,508.00 | 2,696.00 | 3,987.07 | 2,882.52 | 1,999.24 | 2,002.04 |
Depreciation | 376.00 | 342.00 | 310.55 | 254.65 | 185.95 | 168.81 |
Profit Before Tax | 2,132.00 | 2,354.00 | 3,676.52 | 2,627.87 | 1,813.29 | 1,833.23 |
Current Tax | 511.00 | 438.00 | 637.20 | 609.05 | 387.79 | 472.45 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 45.00 | 108.00 | 90.78 | 64.10 | 52.79 | 28.13 |
Reported Net Profit | 1,576.00 | 1,808.00 | 2,948.54 | 1,954.72 | 1,372.71 | 1,332.65 |
Extraordinary Items | 0.74 | 3.07 | -1.65 | -2.45 | 41.46 | 18.78 |
Adjusted Net Profit | 1,575.26 | 1,804.93 | 2,950.19 | 1,957.17 | 1,331.25 | 1,313.87 |
Adjustment below Net Profit | -1.00 | 2.00 | 2.18 | 0.16 | -92.52 | -53.52 |
P & L Balance brought forward | 10,922.00 | 9,967.00 | 7,588.31 | 5,814.44 | 5,636.87 | 4,761.92 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 772.00 | 855.00 | 571.50 | 181.01 | 1,102.62 | 404.18 |
P & L Balance carried down | 11,725.00 | 10,922.00 | 9,967.53 | 7,588.31 | 5,814.44 | 5,636.87 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 424.75 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 1,500.00 | 1,500.00 | 1,500.00 | 1,000.00 | 800.00 | 800.00 |
Dividend Per Share(Rs) | 30.00 | 30.00 | 30.00 | 20.00 | 16.00 | 16.00 |
Earnings Per Share-Unit Curr | 59.47 | 68.23 | 111.08 | 73.64 | 51.71 | 50.20 |
Earnings Per Share(Adj)-Unit Curr | 59.47 | 68.23 | 111.08 | 73.64 | 51.71 | 50.20 |
Book Value | 508.83 | 479.43 | 440.44 | 349.28 | 275.63 | 262.70 |
Book Value(Adj)-Unit Curr | 508.83 | 479.43 | 440.44 | 349.28 | 275.63 | 262.70 |